Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Stankoff

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practiceJoão Carlos Correia de Sa, Laura Airas, Emmanuel Bartholome, et al.
Annals of Neurology|April 11, 2023
Positron Emission Tomography with [<sup>18</sup> F]-DPA-714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease ProgressionMariem Hamzaoui, Jeanne Garcia, Giacomo Boffa, et al.
Multiple Sclerosis and Related Disorders|June 27, 2025
Choroid plexus enlargement and Kappa light chains index reflect distinct pathophysiological processes in Multiple SclerosisNatalia Shor, Vito Ag Ricigliano, Gaspard Martet, et al.
Brain Communications|June 25, 2026
Magnetoencephalography biomarkers for assessing myelin content and neuronal function in acute optic neuritisYsoline Beigneux, Christophe Gitton, Abdul Rauf Anwar, et al.
Journal of Virology|March 22, 2013
Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapyHouria Hendel-Chavez, Marie-Ghislaine de Goër de Herve, Claire Giannesini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 3, 2021
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersCéline Louapre, Michella Ibrahim, Elisabeth Maillart, et al.
NMR in Biomedicine|January 22, 2021
Inflammation-driven glial alterations in the cuprizone mouse model probed with diffusion-weighted magnetic resonance spectroscopy at 11.7 TGuglielmo Genovese, Marco Palombo, Mathieu D Santin, et al.
Nature Reviews. Neurology|January 23, 2021
Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposalFernando Dangond, Alexis Donnelly, Reinhard Hohlfeld, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
Imaging of CNS myelin by positron-emission tomographyBruno Stankoff, Yanming Wang, Michel Bottlaender, et al.
Frontiers in Neurology|April 8, 2020
Germline Genetic Risk Variants for Progressive Multifocal LeukoencephalopathyPeggy S Eis, Christopher D Bruno, Todd A Richmond, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practiceJoão Carlos Correia de Sa, Laura Airas, Emmanuel Bartholome, et al.
Annals of Neurology|April 11, 2023
Positron Emission Tomography with [<sup>18</sup> F]-DPA-714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease ProgressionMariem Hamzaoui, Jeanne Garcia, Giacomo Boffa, et al.
Multiple Sclerosis and Related Disorders|June 27, 2025
Choroid plexus enlargement and Kappa light chains index reflect distinct pathophysiological processes in Multiple SclerosisNatalia Shor, Vito Ag Ricigliano, Gaspard Martet, et al.
Brain Communications|June 25, 2026
Magnetoencephalography biomarkers for assessing myelin content and neuronal function in acute optic neuritisYsoline Beigneux, Christophe Gitton, Abdul Rauf Anwar, et al.
Journal of Virology|March 22, 2013
Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapyHouria Hendel-Chavez, Marie-Ghislaine de Goër de Herve, Claire Giannesini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 3, 2021
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersCéline Louapre, Michella Ibrahim, Elisabeth Maillart, et al.
NMR in Biomedicine|January 22, 2021
Inflammation-driven glial alterations in the cuprizone mouse model probed with diffusion-weighted magnetic resonance spectroscopy at 11.7 TGuglielmo Genovese, Marco Palombo, Mathieu D Santin, et al.
Nature Reviews. Neurology|January 23, 2021
Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposalFernando Dangond, Alexis Donnelly, Reinhard Hohlfeld, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
Imaging of CNS myelin by positron-emission tomographyBruno Stankoff, Yanming Wang, Michel Bottlaender, et al.
Frontiers in Neurology|April 8, 2020
Germline Genetic Risk Variants for Progressive Multifocal LeukoencephalopathyPeggy S Eis, Christopher D Bruno, Todd A Richmond, et al.
Pageof 16